Ir­ish Times Busi­ness Per­son of the Month for Oc­to­ber

The Irish Times - Business - - BUSINESS | NEWS -

Dr Elaine Sul­li­van, co-founder and chief ex­ec­u­tive of early-stage life-sciences com­pany Carrick Ther­a­peu­tics, has been cho­sen as The Ir­ish Times Busi­ness Per­son of the Month for Oc­to­ber, an award run in as­so­ci­a­tion with KPMG.

Carrick last month ob­tained the rights to de­velop and com­mer­cialise a new ground­break­ing ovar­ian can­cer treat­ment known as CT900. Dis­cov­ered by the In­sti­tute of Can­cer Re­search in Lon­don. Carrick has al­ready com­menced prepa­ra­tions for ad­di­tional clin­i­cal tri­als for the drug, which Dr Sul­li­van says has the po­ten­tial to be a “highly ef­fec­tive treat­ment for women with ovar­ian can­cer”.

Carrick also strength­ened its board in Oc­to­ber with the ap­point­ment of Dr Ge­orge Golumbeski, a for­mer vice-pres­i­dent of bio­pharma gi­ant Cel­gene, as its chair­man.

Back­ers

Dr Sul­li­van, a for­mer vice-pres­i­dent for re­search and devel­op­ment at US drugs gi­ant Eli Lilly and its British peer As­traZeneca, founded Carrick two years ago. The com­pany, which raised $95 mil­lion (€83.2 mil­lion) in an ini­tial fund­ing round to co­in­cide with its launch, is fo­cused on de­vel­op­ing pi­o­neer­ing treat­ments to de­feat many of the most ag­gres­sive and re­sis­tant can­cers.

Carrick’s back­ers in­clude Arch Ven­ture Part­ners, Wood­ford In­vest­ment Man­age­ment and GV (formerly Google Ven­tures).

In what was a busy pe­riod for Dr Sul­li­van, she ended the month by be­ing named “best emerg­ing en­tre­pre­neur” in the EY En­tre­pre­neur of the Year awards.

IL­LUS­TRA­TION: PAUL RYDING

Newspapers in English

Newspapers from Ireland

© PressReader. All rights reserved.